Birdwatch Note Rating
2023-11-18 14:05:51 UTC - HELPFUL
Rated by Participant: 87862316201459CCE48B6F17413B86E3A1ADA24CD99D30D6D7BE90164C8A678A
Participant Details
Original Note:
In the trial the effectiveness of the vaccine against severe RSV disease in babies was 81.8%. The clinical trial efficacy & safety data is publicly available. The available data are insufficient to establish a causal relationship between preterm birth & the vaccine https://www.fda.gov/news-events/press-announcements/fda-approves-first-vaccine-pregnant-individuals-prevent-rsv-infants https://www.nejm.org/doi/10.1056/NEJMoa2216480 https://www.fda.gov/media/169361/download
All Note Details